29 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
Underrepresented Individual in Home Country Jurisdiction
LGBTQ+
Did Not Disclose Demographic Background
Board Practices, Corporate Governance … committees and our corporate governance practices. We encourage you to review those portions of our 2022 Form 20-F.
PROPOSAL 1
ELECTION OF DIRECTORS
6-K
ENLV
Enlivex Therapeutics Ltd
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
under the heading “Board Practices, Corporate Governance and Compensation of Executive Officers and Directors” in Exhibit 99.1 is incorporated
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
in Home Country Jurisdiction
LGBTQ+
Did Not Disclose Demographic Background
Board Practices, Corporate Governance and Compensation of Executive … governance practices. We encourage you to review those portions of our 2021 Form 20-F.
The aggregate compensation of our five most highly
424B5
fyg1zvvjc0f4
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
t11qvrnngw ldkde6
9 Feb 21
Prospectus supplement for primary offering
4:56pm
424B5
hjt0igf57ybh4qqay1
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K
EX-99.1
sm27wow5usbcy
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
424B5
id3656p
3 Mar 20
Prospectus supplement for primary offering
5:13pm
424B5
mmo0 3y6penz2
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
almgbt3
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
xl7rz1x
20 Nov 19
Prospectus supplement for primary offering
4:46pm
424B3
zcvaon
10 Jul 19
Prospectus supplement
8:18am
F-3
lowuzts
28 Jun 19
Shelf registration (foreign)
9:48am
F-3
cdyx2dcv
7 Jun 19
Shelf registration (foreign)
3:31pm